Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SEVTAR—A multicenter randomized controlled trial to investigate the impact of prophylactic endoluminal placed vacuum sponge for prevention of anastomotic leakage after low rectal resections

Autor: Leif Schiffmann, Matthias Becker, Leendert Develing, David Varga-Szabo, Caroline Scheidereiter-Krüger, Hubert Zirngibl, Michael Seifert, Lothar Biermann, Claudia Schlüter, Felicitas Tumczak, Arved Weimann, Boris Jansen-Winkeln, Ingo Wallstabe, Frank Schwandner, Sandra Denecke, Clemens Schafmayer, Imad Kamaleddine, Albrecht Stier, Katharina Haegele, Michael Kindler, Sabine Michling, Ernst-Wilhelm Horling, Ulrike Denzer

Publikováno v: Frontiers in Surgery, Vol 9 (2023)

BackgroundLow anterior resection for rectal cancer is commonly associated with a diverting stoma. In general, the stoma is closed 3 months after the initial operation. The diverting stoma reduces the rate of anastomotic leakage as well as the severen

Externí odkaz: https://doaj.org/article/fa2b55ef083f4bb6ba94103d706fb425

PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma

Autor: Marlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, Astrid Monecke, Ines Gockel, Arved Weimann, Guido Schumacher, Ingo Bechmann, Florian Lordick, Sonja Kallendrusch, Justus Körfer

Publikováno v: OncoImmunology, Vol 10, Iss 1 (2021)

Emerging immunotherapies quest for better patient stratification in cancer treatment decisions. Moderate response rates of PD-1 inhibition in gastric and esophagogastric junction cancers urge for meaningful human model systems that allow for investig

Externí odkaz: https://doaj.org/article/c3b19dbf19ac44c8bd1dbe30434846cd

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease

Autor: Stephan C. Bischoff, Palle Bager, Johanna Escher, Alastair Forbes, Xavier Hébuterne, Christian Lodberg Hvas, Francisca Joly, Stansilaw Klek, Zeljko Krznaric, Johann Ockenga, Stéphane Schneider, Raanan Shamir, Kalina Stardelova, Darija Vranesic Bender, Nicolette Wierdsma, Arved Weimann

Publikováno v: Clinical Nutrition, 42(3), 352-379. Churchill Livingstone
Bischoff, S C, Bager, P, Escher, J, Forbes, A, Hébuterne, X, Hvas, C L, Joly, F, Klek, S, Krznaric, Z, Ockenga, J, Schneider, S, Shamir, R, Stardelova, K, Bender, D V, Wierdsma, N & Weimann, A 2023, ' ESPEN guideline on Clinical Nutrition in inflammatory bowel disease ', Clinical Nutrition, vol. 42, no. 3, pp. 352-379 . https://doi.org/10.1016/j.clnu.2022.12.004

The present guideline is an update and extension of the ESPEN scientific guideline on Clinical Nutrition in Inflammatory Bowel Disease published first in 2017. The guideline has been rearranged according to the ESPEN practical guideline on Clinical N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64447538cd65a40cf581374c991d97fb
https://pure.eur.nl/en/publications/20d09bfc-4144-4587-9c7e-3d772ee4ce07

Kosten-Effektivitäts-Analyse des Optifast 52 Programms bei Patienten mit Adipositas Grad III und Diabetes mellitus Typ 2

Autor: Helena Thiem, Reinhard P.T. Rychlik, Arved Weimann

Publikováno v: Aktuelle Ernährungsmedizin. 47:444-452

Zusammenfassung Hintergrund Adipositas stellt für eine Vielzahl weiterer Erkrankungen einen wesentlichen Risikofaktor dar, darunter insbesondere Diabetes mellitus Typ 2 (DMT2). DMT2 als Adipositas-assoziierte Folgeerkrankung bedeutet sowohl aus medi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1d448618cd46dbd302e148dd00d18d
https://doi.org/10.1055/a-1955-0935